These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 27838279)
1. Post-marketing surveillance of generic amoxicillin using a microbiological assay and pharmacokinetic approach in rats. de Mattos LIS; Ferraris FK; Machado TSC; de Brito TM; Chaves AS; Pereira HM; Pinto DP; da Silva DMD; Amendoeira FC Int J Antimicrob Agents; 2016 Dec; 48(6):753-756. PubMed ID: 27838279 [TBL] [Abstract][Full Text] [Related]
2. In vitro equivalence of generic and branded amoxicillin tablet by microbiological assay method. Avianto P; Mahfudz ; Suharjono ; Isnaeni ; Alderman CP J Basic Clin Physiol Pharmacol; 2020 Jan; 30(6):. PubMed ID: 31939272 [TBL] [Abstract][Full Text] [Related]
3. Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers. Del Tacca M; Pasqualetti G; Di Paolo A; Virdis A; Massimetti G; Gori G; Versari D; Taddei S; Blandizzi C Br J Clin Pharmacol; 2009 Jul; 68(1):34-42. PubMed ID: 19660001 [TBL] [Abstract][Full Text] [Related]
4. Plasma pharmacokinetics of a generic amoxycillin and the innovator brand: a comparison. Goonetilleke AK; Munasingha JM; Guruge DS; Samaraweera DS; Weerasena OV Ceylon Med J; 1998 Mar; 43(1):16-8. PubMed ID: 9624838 [TBL] [Abstract][Full Text] [Related]
5. In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products. Rodriguez CA; Agudelo M; Zuluaga AF; Vesga O Int J Antimicrob Agents; 2017 Feb; 49(2):189-197. PubMed ID: 27988068 [TBL] [Abstract][Full Text] [Related]
6. Evaluation and comparison of in-vitro dissolution profiles for different brands of amoxicillin capsules. Kassaye L; Genete G Afr Health Sci; 2013 Jun; 13(2):369-75. PubMed ID: 24235938 [TBL] [Abstract][Full Text] [Related]
7. Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator. Vesga O; Agudelo M; Salazar BE; Rodriguez CA; Zuluaga AF Antimicrob Agents Chemother; 2010 Aug; 54(8):3271-9. PubMed ID: 20547818 [TBL] [Abstract][Full Text] [Related]
8. [Generic drugs: we must cut pharmaceutical spending but undertaking drug quality]. Carrillo Norte JA; Postigo Mota S Rev Enferm; 2012 Feb; 35(2):10-9. PubMed ID: 22670381 [TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of the switchability of generic products. Karalis V; Bialer M; Macheras P Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332 [TBL] [Abstract][Full Text] [Related]
10. Generic antibiotic drugs: is effectiveness guaranteed? Gauzit R; Lakdhari M Med Mal Infect; 2012 Apr; 42(4):141-8. PubMed ID: 22480963 [TBL] [Abstract][Full Text] [Related]
11. Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: the case of meropenem. Agudelo M; Rodriguez CA; Pelaez CA; Vesga O Antimicrob Agents Chemother; 2014; 58(2):1005-18. PubMed ID: 24277034 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin. Rodriguez CA; Agudelo M; Zuluaga AF; Vesga O BMC Infect Dis; 2010 Jun; 10():153. PubMed ID: 20525378 [TBL] [Abstract][Full Text] [Related]
13. Relative potency of different generic brands of meropenem, colistin and fosfomycin: Implications for antimicrobial therapy and antimicrobial formulary. Das P; Jana B; Dhar K; Goel G; Bhattacharya S; Chandy M Indian J Med Microbiol; 2019; 37(1):95-98. PubMed ID: 31424016 [TBL] [Abstract][Full Text] [Related]
14. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms. Meredith PA Curr Med Res Opin; 2009 Sep; 25(9):2179-89. PubMed ID: 19601710 [TBL] [Abstract][Full Text] [Related]
15. Bioequivalence and in vitro antimicrobial activity between generic and brand-name levofloxacin. Sun HY; Liao HW; Sheng MH; Tai HM; Kuo CH; Sheng WH Diagn Microbiol Infect Dis; 2016 Jul; 85(3):347-351. PubMed ID: 27181716 [TBL] [Abstract][Full Text] [Related]
16. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration. Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300 [TBL] [Abstract][Full Text] [Related]
17. Is bioavailability altered in generic versus brand anticonvulsants? Jankovic SM; Ignjatovic Ristic D Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):329-32. PubMed ID: 25440299 [TBL] [Abstract][Full Text] [Related]
18. Bioequivalence of generic drugs. Andrade C J Clin Psychiatry; 2015 Sep; 76(9):e1130-1. PubMed ID: 26455677 [TBL] [Abstract][Full Text] [Related]
19. Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam. Agudelo M; Rodriguez CA; Zuluaga AF; Vesga O Int J Antimicrob Agents; 2015 Feb; 45(2):161-7. PubMed ID: 25481459 [TBL] [Abstract][Full Text] [Related]
20. Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence? Dupont AG; Heller F Acta Clin Belg; 2009; 64(5):406-14. PubMed ID: 19999388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]